VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 71 filers reported holding VERONA PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,189,000 | -16.0% | 761,205 | 0.0% | 0.16% | -21.5% |
| Q1 2022 | $3,798,000 | -25.7% | 761,205 | 0.0% | 0.20% | -17.4% |
| Q4 2021 | $5,115,000 | +22.6% | 761,205 | 0.0% | 0.24% | +12.0% |
| Q3 2021 | $4,171,000 | -16.2% | 761,205 | 0.0% | 0.22% | -2.3% |
| Q2 2021 | $4,978,000 | -29.0% | 761,205 | -9.2% | 0.22% | -23.5% |
| Q1 2021 | $7,009,000 | -61.6% | 838,360 | -67.9% | 0.29% | -63.1% |
| Q4 2020 | $18,261,000 | +62.5% | 2,608,755 | +44.9% | 0.78% | +40.3% |
| Q3 2020 | $11,237,000 | +224.1% | 1,800,747 | +143.1% | 0.56% | +149.1% |
| Q2 2020 | $3,467,000 | +13.6% | 740,740 | 0.0% | 0.22% | +9.8% |
| Q1 2020 | $3,052,000 | -28.3% | 740,740 | 0.0% | 0.20% | -25.5% |
| Q4 2019 | $4,259,000 | +25.8% | 740,740 | 0.0% | 0.27% | -52.8% |
| Q3 2019 | $3,385,000 | -10.4% | 740,740 | 0.0% | 0.58% | +9.6% |
| Q2 2019 | $3,778,000 | -21.5% | 740,740 | 0.0% | 0.53% | -25.7% |
| Q1 2019 | $4,815,000 | -32.6% | 740,740 | 0.0% | 0.71% | -29.2% |
| Q4 2018 | $7,148,000 | -22.9% | 740,740 | 0.0% | 1.01% | +36.7% |
| Q3 2018 | $9,267,000 | -8.4% | 740,740 | 0.0% | 0.74% | -27.6% |
| Q2 2018 | $10,119,000 | -31.7% | 740,740 | 0.0% | 1.02% | -45.3% |
| Q1 2018 | $14,815,000 | +68.5% | 740,740 | 0.0% | 1.86% | +50.7% |
| Q4 2017 | $8,793,000 | -22.7% | 740,740 | 0.0% | 1.23% | -16.7% |
| Q3 2017 | $11,370,000 | +31.6% | 740,740 | 0.0% | 1.48% | +43.3% |
| Q2 2017 | $8,637,000 | – | 740,740 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |